entity

DOP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
4Hypotheses
4Analyses
4Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

calcium-dysregulation-comparison

mechanism · 6468 words

locus-coeruleus

brain_region · 3396 words

PNMT Protein

protein · 3289 words

Locus Coeruleus Noradrenergic Neurons

cell · 2822 words

Noradrenergic System in Neurodegeneration

cell · 2520 words

Outgoing (4)

TargetRelationTypeStr
SRCbindsprotein0.90
Breast Cancercontributes_todisease0.90
MAPK1bindsprotein0.85
Breast Cancerrisk_factor_fordisease0.85

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio 0.494 neuroscience Circuit-level neural dynamics in neurode
Correcting Gut Microbial Dopamine Imbalance to Support Syste 0.412 neurodegeneration What are the mechanisms by which gut mic
BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopa 0.396 neurodegeneration What molecular mechanisms underlie Atrem
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis 0.364 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (4)

Scientific analyses that reference this entity

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.467

Do tau-specific HSP90 conformational states exist that differ from other client

structural biology | 2026-04-10 | 0 hypotheses

Astrocyte reactivity subtypes in neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.554

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Gene therapy for Parkinson's disease: current landscape, translational challenge [PMID:41837837] Evola V, Parmar MS Expert review of neurotherapeu 2026 0
Striatal Dysregulation of Angpt2 and Circadian Gene Expression in a Rotenone Rat [PMID:41925987] Al Saeedy DY, Hawkins E, Dozmorov MG, Tr J Mol Neurosci 2026 0
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders [PMID:41699128] ["Bolsewig K", "Bellomo G", "Hok-A-Hin Y Nature medicine 2026 0
Plasma pTau 217/β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertain [PMID:41562409] Benina N, Buitrago L, De Simone FI, Radw Brain 2026 0
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by [PMID:39881147] ["Bolsewig K", "Willemse E", "S\u00e1nch Nature communications 2025 0
Neurosurgical gene therapy for central nervous system diseases. [PMID:39191071] Patel RV, Nanda P, Richardson RM Neurotherapeutics : the journa 2024 0
Characterization of Vps13b-mutant mice reveals neuroanatomical and behavioral ph [PMID:37573958] ["Montillot C", "Skutunova E", "Ayushma" Neurobiology of disease 2023 0
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neu [PMID:36692274] ["Motta C", "Assogna M", "Bonomi C", "Di European journal of neurology 2023 0
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC d [PMID:34763085] Tai CH, Lee NC, Chien YH, Byrne BJ, Mura Molecular therapy : the journa 2022 0
Gene therapy restores dopamine transporter expression and ameliorates pathology [PMID:34011628] Ng J, Barral S, De La Fuente Barrigon C, Science translational medicine 2021 0
Current Clinical Applications of In Vivo Gene Therapy with AAVs. [PMID:33309881] Mendell JR, Al-Zaidy SA, Rodino-Klapac L Molecular therapy : the journa 2021 0
Targeting autophagy using small-molecule compounds to improve potential therapy [PMID:34729301] Zhang K, Zhu S, Li J, Jiang T, Feng L, P Acta pharmaceutica Sinica. B 2021 0
Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal car [PMID:33547425] Lieberwirth JK, Joset P, Heinze A, Hents European journal of human gene 2021 0
Graphene bilayers with a twist. [PMID:33208935] ["Andrei E", "MacDonald A"] Nature materials 2020 0
Reconstruction of cell spatial organization from single-cell RNA sequencing data [PMID:32541867] ["Ren X", "Zhong G", "Zhang Q", "Zhang L Cell research 2020 0
Gene therapy for neurodegenerative disorders: advances, insights and prospects. [PMID:32963936] Chen W, Hu Y, Ju D Acta pharmaceutica Sinica. B 2020 0
Environmental Regulation, Technological Innovation, and Export Competitiveness: [PMID:32102174] Liu J, Xie J International journal of envir 2020 0
Predicting Subjective Recovery from Lower Limb Surgery Using Consumer Wearables. [PMID:33442582] Karas M, Marinsek N, Goldhahn J, Foschin Digital biomarkers 2020 0
Ligand entry in human ileal bile acid-binding protein is mediated by histidine p [PMID:30886237] ["Horv\u00e1th G", "Egyed O", "Tang C", Scientific reports 2019 0
[Skin Changes in POEMS Syndrome]. [PMID:30988219] ["Kuwabara S"] Brain and nerve = Shinkei kenk 2019 0